The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease

INTRODUCTION: Parkinson’s therapeutic interventions are only symptomatic. An optimal treatment should therefore address the largest number of motor and non-motor symptoms, to manage patients at best. Safinamide is one of the most recent approved drugs for fluctuating patients, in add-on to levodopa,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbruzzese, Giovanni, Barone, Paolo, Lopiano, Leonardo, Stocchi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203199/
https://www.ncbi.nlm.nih.gov/pubmed/34140766
http://dx.doi.org/10.2147/DDDT.S302673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203199/
https://www.ncbi.nlm.nih.gov/pubmed/34140766
http://dx.doi.org/10.2147/DDDT.S302673

Ejemplares similares